An inventory of short term and long term changes in gene expression under interferon β treatment of relapsing remitting MS patients.
Curr Pharm Des.
2012;18(29):4475-84. doi: 10.2174/138161212802502215. Review. PubMed PMID:
22612748.
Elevated type I interferon-like activity in a subset of multiple sclerosis patients: molecular basis and clinical relevance.
J Neuroinflammation.
2012 Jun 22;9:140. doi: 10.1186/1742-2094-9-140. PubMed PMID:
22727118; PubMed Central PMCID:
PMC3464734.
What would you like to do?